Please enable JavaScript to continue using this application.

Compare $CRDF vs $EQ | Chartloom

Compare

$CRDF vs $EQ

Cardiff Oncology Inc · Equillium Inc

CRDF

Cardiff Oncology Inc

Equillium Inc

Compare $CRDF vs $EQ

Comparing Cardiff Oncology Inc and Equillium Inc

CRDFCardiff Oncology Inc

EQEquillium Inc

CRDFCardiff Oncology Inc

Market cap

$84M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

244.08x

Rev growth (TTM)

-7.0%

YTD performance

-59.4%

52W performance

-54.6%

FCF yield

-48.7%

EQEquillium Inc

Market cap

$89M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-7.8%

52W performance

-4.1%

FCF yield

-22.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRDF

Detailed metrics comparison

CRDF

Cardiff Oncology Inc

Equillium Inc

Market Cap

CRDF$84M

EQ$89M

Enterprise Value

CRDF$75M

EQ$32M

Price

CRDF$1.08

EQ$1.41

P/E Ratio

CRDFN/A

EQN/A

P/S Ratio

CRDF165.40x

EQ2.18x

EV/Sales

CRDF147.30x

EQ0.78x

EV/EBITDA

CRDF0.00x

EQ0.00x

P/B Ratio

CRDF3.28x

EQ1.60x

P/FCF Ratio

CRDFN/A

EQN/A

EV/FCF

CRDF-1.83x

EQ-1.59x

PEG Ratio

CRDFN/A

EQN/A

Forward P/E (NTM)

CRDFN/A

EQN/A

Forward P/S (NTM)

CRDF244.08x

EQN/A

Revenue (TTM)

CRDF$508K

EQ$0

Revenue Growth (YoY)

CRDF-7.0%

EQN/A

Forward Rev Growth

CRDF-19.6%

EQ0.0%

Gross Margin (TTM)

CRDF100.0%

EQ0.0%

Operating Margin (TTM)

CRDF0.0%

EQ0.0%

EBITDA Margin (TTM)

CRDF-8251.0%

EQ0.0%

Net Margin (TTM)

CRDF-7889.0%

EQ0.0%

FCF Margin (TTM)

CRDF-8054.3%

EQN/A

Net Income (TTM)

CRDF$-40M

EQ$-18M

FCF (TTM)

CRDF$-41M

EQ$-20M

EPS (TTM)

CRDF-$0.59

EQ-$0.15

ROE (TTM)

CRDF-10308.0%

EQ-6143.0%

ROA (TTM)

CRDF-7551.0%

EQ-5372.0%

ROIC (TTM)

CRDF-10308.0%

EQ-6143.0%

Cash

CRDF$9M

EQ$57M

Debt

CRDF$0

EQ$0

Net Cash/Debt

CRDF$9M

EQ$57M

Current Ratio (TTM)

CRDF3.30x

EQ23.40x

Quick Ratio (TTM)

CRDF3.21x

EQ23.07x

Debt/Equity (TTM)

CRDF0.00x

EQ0.00x

Debt/Assets (TTM)

CRDF0.0%

EQ0.0%

Interest Coverage (TTM)

CRDFN/A

EQN/A

Net Debt/EBITDA (TTM)

CRDF0.00x

EQ0.00x

Beta

CRDF1.49

EQ2.07

52W Performance

CRDF-54.6%

EQ-4.1%

YTD Performance

CRDF-59.4%

EQ-7.8%

% from 52W High

CRDF-67.4%

EQ-60.2%

% from 52W Low

CRDF42.7%

EQ85.5%

Asset Turnover (TTM)

CRDF0.01x

EQ1.12x

FCF Yield (TTM)

CRDF-48.7%

EQ-22.5%

Earnings Yield (TTM)

CRDF-47.7%

EQ-20.2%

Dividend Yield (TTM)

CRDFN/A

EQN/A

Rule of 40

CRDF-8,061.3

EQ0.0

EV/GP/RG

CRDFN/A

EQN/A

Ticker research

View CRDF research View EQ research

Metric	CRDF Cardiff Oncology Inc	EQ Equillium Inc
Market & Valuation
Market Cap	$84M	$89M
Enterprise Value	$75M	$32M
Price	$1.08	$1.41
P/E Ratio	N/A	N/A
P/S Ratio	165.40x	2.18x
EV/Sales	147.30x	0.78x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.28x	1.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.83x	-1.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	244.08x	N/A
Revenue & Growth
Revenue (TTM)	$508K	$0
Revenue Growth (YoY)	-7.0%	N/A
Forward Rev Growth	-19.6%	0.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-8251.0%	0.0%
Net Margin (TTM)	-7889.0%	0.0%
FCF Margin (TTM)	-8054.3%	N/A
Net Income (TTM)	$-40M	$-18M
FCF (TTM)	$-41M	$-20M
EPS (TTM)	-$0.59	-$0.15
ROE (TTM)	-10308.0%	-6143.0%
ROA (TTM)	-7551.0%	-5372.0%
ROIC (TTM)	-10308.0%	-6143.0%
Financial Health
Cash	$9M	$57M
Debt	$0	$0
Net Cash/Debt	$9M	$57M
Current Ratio (TTM)	3.30x	23.40x
Quick Ratio (TTM)	3.21x	23.07x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.49	2.07
52W Performance	-54.6%	-4.1%
YTD Performance	-59.4%	-7.8%
% from 52W High	-67.4%	-60.2%
% from 52W Low	42.7%	85.5%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	1.12x
FCF Yield (TTM)	-48.7%	-22.5%
Earnings Yield (TTM)	-47.7%	-20.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,061.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRDF research	View EQ research

Valuation

P/S Ratio

2.18x

CRDF

165.40x

EV/FCF

CRDF

-1.83x

-1.59x

Growth & revenue

Revenue Growth TTM

CRDF

-7.0%

Forward Revenue Growth

0.0%

CRDF

-19.6%

Profitability & performance

Gross Margin

CRDF

100.0%

0.0%

ROE

-6143.0%

CRDF

-10308.0%

FCF Yield %

-22.5%

CRDF

-48.7%

52-Week Performance

-4.1%

CRDF

-54.6%

Detailed metrics comparison

CRDF

Cardiff Oncology Inc

Equillium Inc

Market Cap

CRDF$84M

EQ$89M

Enterprise Value

CRDF$75M

EQ$32M

Price

CRDF$1.08

EQ$1.41

P/E Ratio

CRDFN/A

EQN/A

P/S Ratio

CRDF165.40x

EQ2.18x

EV/Sales

CRDF147.30x

EQ0.78x

EV/EBITDA

CRDF0.00x

EQ0.00x

P/B Ratio

CRDF3.28x

EQ1.60x

P/FCF Ratio

CRDFN/A

EQN/A

EV/FCF

CRDF-1.83x

EQ-1.59x

PEG Ratio

CRDFN/A

EQN/A

Forward P/E (NTM)

CRDFN/A

EQN/A

Forward P/S (NTM)

CRDF244.08x

EQN/A

Revenue (TTM)

CRDF$508K

EQ$0

Revenue Growth (YoY)

CRDF-7.0%

EQN/A

Forward Rev Growth

CRDF-19.6%

EQ0.0%

Gross Margin (TTM)

CRDF100.0%

EQ0.0%

Operating Margin (TTM)

CRDF0.0%

EQ0.0%

EBITDA Margin (TTM)

CRDF-8251.0%

EQ0.0%

Net Margin (TTM)

CRDF-7889.0%

EQ0.0%

FCF Margin (TTM)

CRDF-8054.3%

EQN/A

Net Income (TTM)

CRDF$-40M

EQ$-18M

FCF (TTM)

CRDF$-41M

EQ$-20M

EPS (TTM)

CRDF-$0.59

EQ-$0.15

ROE (TTM)

CRDF-10308.0%

EQ-6143.0%

ROA (TTM)

CRDF-7551.0%

EQ-5372.0%

ROIC (TTM)

CRDF-10308.0%

EQ-6143.0%

Cash

CRDF$9M

EQ$57M

Debt

CRDF$0

EQ$0

Net Cash/Debt

CRDF$9M

EQ$57M

Current Ratio (TTM)

CRDF3.30x

EQ23.40x

Quick Ratio (TTM)

CRDF3.21x

EQ23.07x

Debt/Equity (TTM)

CRDF0.00x

EQ0.00x

Debt/Assets (TTM)

CRDF0.0%

EQ0.0%

Interest Coverage (TTM)

CRDFN/A

EQN/A

Net Debt/EBITDA (TTM)

CRDF0.00x

EQ0.00x

Beta

CRDF1.49

EQ2.07

52W Performance

CRDF-54.6%

EQ-4.1%

YTD Performance

CRDF-59.4%

EQ-7.8%

% from 52W High

CRDF-67.4%

EQ-60.2%

% from 52W Low

CRDF42.7%

EQ85.5%

Asset Turnover (TTM)

CRDF0.01x

EQ1.12x

FCF Yield (TTM)

CRDF-48.7%

EQ-22.5%

Earnings Yield (TTM)

CRDF-47.7%

EQ-20.2%

Dividend Yield (TTM)

CRDFN/A

EQN/A

Rule of 40

CRDF-8,061.3

EQ0.0

EV/GP/RG

CRDFN/A

EQN/A

Ticker research

View CRDF research View EQ research

Metric	CRDF Cardiff Oncology Inc	EQ Equillium Inc
Market & Valuation
Market Cap	$84M	$89M
Enterprise Value	$75M	$32M
Price	$1.08	$1.41
P/E Ratio	N/A	N/A
P/S Ratio	165.40x	2.18x
EV/Sales	147.30x	0.78x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.28x	1.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.83x	-1.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	244.08x	N/A
Revenue & Growth
Revenue (TTM)	$508K	$0
Revenue Growth (YoY)	-7.0%	N/A
Forward Rev Growth	-19.6%	0.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-8251.0%	0.0%
Net Margin (TTM)	-7889.0%	0.0%
FCF Margin (TTM)	-8054.3%	N/A
Net Income (TTM)	$-40M	$-18M
FCF (TTM)	$-41M	$-20M
EPS (TTM)	-$0.59	-$0.15
ROE (TTM)	-10308.0%	-6143.0%
ROA (TTM)	-7551.0%	-5372.0%
ROIC (TTM)	-10308.0%	-6143.0%
Financial Health
Cash	$9M	$57M
Debt	$0	$0
Net Cash/Debt	$9M	$57M
Current Ratio (TTM)	3.30x	23.40x
Quick Ratio (TTM)	3.21x	23.07x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.49	2.07
52W Performance	-54.6%	-4.1%
YTD Performance	-59.4%	-7.8%
% from 52W High	-67.4%	-60.2%
% from 52W Low	42.7%	85.5%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	1.12x
FCF Yield (TTM)	-48.7%	-22.5%
Earnings Yield (TTM)	-47.7%	-20.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,061.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRDF research	View EQ research